These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 17562671
1. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D, GRACE Investigators. Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671 [Abstract] [Full Text] [Related]
2. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK. J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401 [Abstract] [Full Text] [Related]
3. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ. Am J Cardiol; 2008 Dec 15; 102(12):1618-23. PubMed ID: 19064015 [Abstract] [Full Text] [Related]
4. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB. Am Heart J; 2004 Mar 15; 147(3):463-7. PubMed ID: 14999195 [Abstract] [Full Text] [Related]
5. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A. Pharmacotherapy; 2007 May 15; 27(5):691-6. PubMed ID: 17461704 [Abstract] [Full Text] [Related]
6. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Reaume KT, Regal RE, Dorsch MP. Ann Pharmacother; 2008 Apr 15; 42(4):550-7. PubMed ID: 18319394 [Abstract] [Full Text] [Related]
10. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents. Uchida Y, Mori F, Ogawa H, Takagi A, Hagiwara N. J Cardiol; 2010 May 15; 55(3):362-9. PubMed ID: 20350510 [Abstract] [Full Text] [Related]
15. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Rubboli A, Halperin JL. Thromb Haemost; 2008 Nov 15; 100(5):752-3. PubMed ID: 18989515 [No Abstract] [Full Text] [Related]
16. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. Depta JP, Cannon CP, Fonarow GC, Zhao X, Peacock WF, Bhatt DL, Get With The Guidelines Steering Committee and Investigators. Am J Cardiol; 2009 Nov 01; 104(9):1171-8. PubMed ID: 19840557 [Abstract] [Full Text] [Related]